Bengaluru: In a poignant turn of events, on the day of India’s monumental Aditya-L1 mission launch, S Somnath, the esteemed Chief of the Indian Space Research Organisation (ISRO), received the startling news of a cancer diagnosis. Confirmed during an interview with Tarmak Media House, Somanath disclosed the discovery of a growth during a routine medical scan.
According to media reports, “There were some health issues during the Chandrayaan-3 mission launch. However, it was not clear to me at the time, I did not have a clear understanding about it,” recounted Somanath.
The revelation of his cancer diagnosis sent shockwaves not only through S Somanath’s personal life but also reverberated within his family and among his colleagues. This unforeseen development juxtaposed with the momentous Aditya-L1 mission launch, presenting a profound personal challenge alongside his professional achievements as the ISRO Chief.
As India’s pioneering space-based solar observatory, Aditya L1, embarked on its mission to explore the mysteries of the Sun on September 2, 2023, Somanath underwent a routine medical scan. However, this seemingly ordinary procedure unearthed an unexpected growth in his stomach.
Prompted by this revelation, Somanath promptly traveled to Chennai for further scans, which confirmed the presence of a hereditary disease. Within a matter of days, it became apparent that he faced a significant health hurdle in addition to his demanding professional obligations.
Undergoing surgery followed by chemotherapy, Somanath’s journey towards recovery was marked by resilience and fortitude. “It was a shock for the family. However, now I see cancer and its treatment as a solution,” he reflected, demonstrating remarkable strength of character and an unwavering spirit in the face of adversity.
While acknowledging his uncertainties about a complete cure, Somnath emphasized the ongoing nature of his battle against cancer. Nonetheless, his recovery has defied expectations. After a mere four days in the hospital, he resumed his duties at ISRO, returning to work on the fifth day without experiencing any discomfort.
“I will be undergoing regular checkups and scans. But, now I am completely cured, and have resumed my duties,” Somanath affirmed, embodying resilience and determination in the face of adversity.
